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Background: Health-Related Quality of Life (HRQoL) and functional exercise capacity are important area of
therapeutic interventions needed to improve the general health of People Living with HIV/AIDS (PLWH). However,
the relationship between self-report and Performance-based Measure of Functional Capacity (PMFC) of PLWH is still
obscure. This study compared the HRQoL and PMFC between a homogenous sample of clinical stage I PLWH and
apparently healthy controls.
Methods: This case–control study involved 74 consenting participants (37 PLWH and 37 controls) who completed
the self-report SF-12 questionnaire and PMFC assessment using Six Minute Walk Test (6MWT). PMFC was expressed
in terms of Six-Minute Walk Distance (6MWD), Six-Minute Walk Work (6MWW) and Maximum oxygen uptake
(VO2max). Data were analyzed using descriptive statistics of mean and inferential statistics of independent t-test,
ANOVA and Pearson’s product moment correlation. Alpha level was set at 0.05.
Results: There was no significant difference in the SF-12 Physical-health Component Score (PCS) of PLWH and the
controls (p = 0.782). However, the SF-12 Mental-health Component Score (MCS) of PLWH was higher than that of
controls (p = 0.040). 6MWD, 6MWW and VO2max were significantly lower for PLWH (p < 0.05). Among PLWH, there was
no significant gender differences in the PMFC (p > 0.05) while PCS was higher among females. There was no significant
correlation between PMFC variables and each of PCS and MCS for PLWH and controls (p > 0.05) respectively.
Conclusion: Self-report physical health of clinical stage 1 PLWH and controls was comparable, while self-report mental
health capacity was higher in PLWH than the controls. PMFC of PLWH was significantly lower compared to healthy
controls without gender bias. Overall, self-report and performance-based measure of physical functional capacity of
PLWH was not inter-related. Therefore understanding the factors that may influence exercise capacity of PLWH may
help to develop effective exercise programmes for PLWH.
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The Human Immune-deficiency Virus/Acquired Im-
munodeficiency Syndrome (HIV/AIDS) epidemic is on
the increase around the world with about 33.2 million
people living with the disease worldwide [1,2]. Africa is
the most affected region with 1.8 – 1.9 million people
living with HIV [3]. As at 2003, Nigeria was estimated to* Correspondence: doziembada@yahoo.com
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reproduction in any medium, provided the orhave the third highest number of people living with HIV/
AIDS in the world, after South Africa and India [4]. There
are varying reports on the prevalence rate of HIV/AIDS in
Nigeria in the recent years; however, all the reports sug-
gest an upward trend in the prevalence [3,5,6]. The WHO
estimates that 3.1% of adults aged 15–49 years are HIV
positive in Nigeria [3].
HIV/AIDS is a life-long disease that poses severe threats
to the health of millions ensuing in morbidity and mortal-
ity around the world [7] and it maintains an insolent
stance against interventions as no cure or vaccine hasLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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advances in medical and pharmacological management of
patients with HIV/AIDS with reported successes but not
without attendant costs and adverse side effects [10,11].
Complementarily, therapeutic exercise is one of the ap-
proaches being explored to help deal with the complica-
tions and symptoms of HIV/AIDS [12]. The HIV infects
cells of the immune system, destroying or impairing their
function leading to progressive deterioration of the im-
mune system called "immune deficiency" [3]. Presentations
associated with chronic HIV infection that eventually lead
to disability and mortality includes muscle wasting, muscle
weakness, fatigue, impaired functional work capacity, de-
pression and decreased quality of life [7].
Various reports have shown that the presence of HIV/
AIDS as well as the symptoms and complications associ-
ated with HIV/AIDS have a negative effect on the quality
of life of People Living with HIV/AIDS (PLWH) [6-9].
Health-Related Quality of Life (HRQoL) refers to quality
of life in a clinical setting that includes those dimensions
such as global health perceptions, symptom status, func-
tional status, biologic and physiologic variables, individual
and environmental characteristics directly affected by the
overall state of health [13,14]. Research on health-related
outcomes such as HRQoL and functional exercise capacity
of PLWH are acclaimed to be significant areas for thera-
peutic intervention needed to improve the general health
of PLWH [15,16].
Functional exercise capacity is believed to be depressed
in PLWH [17-19]. The mechanism explaining the rela-
tionship between HIV/AIDS and functional exercise cap-
acity is somewhat intricate and complex. Meanwhile, the
pathophysiology of the decreased functional exercise
capacity has been associated with the effects of HIV/AIDS
on anaerobic metabolism, muscle fatigue, and eventual
muscle wasting in PLWH [20-23]. Similarly, the immune
system of the PLWH and several immunological variables
including HIV-1 ribonucleic acid viral load and CD4 cell
count has been implicated for decreased functional exer-
cise capacity in PLWH [24,25]. Furthermore, there are
available reports suggesting that psychological health such
as quality of life decreases as HIV/AIDS progresses,
and this may affect the exercise capacity of PLWH
[16,20-22,26].
An assessment of functional exercise capacity and the
factors that may influence the outcome of exercise in
PLWH are required in designing an exercise program.
The Six Minute Walk Test (6MWT) has been accepted as
one of the important performance-based tool in the as-
sessment of functional exercise capacity and it has been
used extensively in various populations including HIV/
AIDS [27,28]. In the same vein, patient’s self-reported
functional capacity assessed using questionnaires based on
indicators of functioning on different activities of dailyliving have been reported in some studies as valid [29-32].
However, comparison of performance-based and self-rated
functional capacity has been reported in literature but
with variable results [32-34]. In addition, discrepancies
exist in literature as to what extent self-reporting can
replace performance based testing [35]. However, there is
an apparent dearth of studies comparing self-report
and Performance-based Measure of Functional Capacity
(PMFC) of PLWH. This study compared the HRQoL and
PMFC between a homogenous sample of clinical stage I
PLWH and apparently healthy controls.Methods
A total of 74 participants (37 PLWH (15 (40.5%) males
and 22 (59.5%) females) and 37 age and sex matched ap-
parently healthy controls) volunteered for the study.
Consenting PLWH in this study were recruited from the
Virology Research Clinic (VRC) of Obafemi Awolowo
University Teaching Hospitals Complex (OAUTHC) Ile-
Ife, Nigeria. In order to ensure homogeneity of sample,
PLWH in clinical stage I of the disease who were 18 years
and older and were recruited. Clinical stage I of HIV/AIDS
refers to asymptomatic/acute HIV infection, with persist-
ent generalized lymphadenopathy [36,37]. All the PLWH
volunteers were on anti-retroviral therapy (HAART).
Consenting participants that had a history of unstable an-
gina and myocardial infarction during the previous month
and those that were already involved in an exercise pro-
gram were also excluded. The apparently controls in this
study included patients’ relatives and health workers at the
VRC. The ethical approval for this study was obtained
from the ethical committee of the OAUTHC. The VRC
gave permission for the study to be carried out at the
centre. Each participant gave informed consent to partici-
pate in the study. The participants’ ages were recorded
while weight and height were also measured and recorded.
Health-Related Quality of Life (HRQoL) was assessed
using the Medical Outcomes Study Short-Form 12 ques-
tionnaire (SF-12). As a generic instrument, the SF-12
has been shown to be valid in both apparently healthy
individuals and PLWH [38-40]. The SF-12 is a 12-item
version of the Medical outcomes study Short Form-36
(SF-36) addressing physical functioning, role limitations
due to physical health, role limitations due to emotional
health, social functioning, bodily pain, general health
perceptions, vitality, and mental health [40-42]. The
SF-12 reduces item redundancy and the burden of data
requirements for both investigators and patients [41].
The SF-12 yields two summary scores; the Physical-
health Component Score (PCS) and the Mental-health
Component Score (MCS). The participants filled the
questionnaire between 2–3 minutes while sitting com-
fortably on a chair. The PCS of the SF-12 was used
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capacity.
Performance-based Measure of Functional Capacity
(PMFC) was assessed using the 6-minute walk test
(6MWT) in accordance with the American Thoracic So-
ciety [43]. This test measures the distance that a partici-
pant can quickly walk on a flat, hard surface in a period
of 6 minutes referred to as the 6-minute walk distance
(6MWD). A distance of 30 m was marked on the hall-
way with white chalk. The participants were then asked
to walk back and forth in the hallway for six minute
from one end of the 30 m distance mark to another,
pivoting briskly at each end and continue walking with-
out hesitation. Participants that became exhausted were
permitted to slow down, to stop, and to rest as neces-
sary. They were allowed to lean against the wall while
resting, but resume walking as soon as they were able to.
If the participant stopped before the 6 minutes were up
and refused to continue, a chair was taken to the partici-
pant to sit on, and the walk discontinued. When the test
was completed, the spot where the participant stopped
was marked and the total distance walked (i.e. 6MWD)
in meters was recorded. No encouragement was given
during the performance of the test. Data from partici-
pants that fail to complete the test were excluded from
analysis. PMFC was expressed in terms of Six-Minute
Walk Distance (6MWD), Six-Minute Walk Work
(6MWW) and Maximum oxygen uptake (VO2max).Computations
I.
Six Minute Walk Work 6MWWð Þ kg=mð Þ
¼ 6MWD  body weight
[44].
II.
Maximum oxygen uptake VO2maxð Þ mL=kg=minuteð Þ
¼ speed mmin 1ð ÞX 0:1ð Þ þ 3:5
[45].Table 1 Independent t-test comparison of the general
characteristics of PLWH and control group
PLWH Control group
Variable X±SD X±SD t - cal p-value
Age 35.68 ± 7.71 35.73 ± 7.88 −0.30 0.976
HT 1.67 ± 0.79 1.66 ± 0.08 0.344 0.739
WT 63.49 ± 12.25 67.12 ± 11.35 −1.324 0.190
BMI 22.77 ± 4.17 24.31 ± 4.24 −1.583 0.118
Abbreviations: HT Height, WT Weight, BMI Body mass index.Statistical analysis
Statistical Package for Social Sciences (SPSS) software
(version 16) was used for the data analysis. Data were
analyzed using descriptive statistics of mean and stand-
ard deviation. Inferential statistics of independent t-test
was used to compare variables between the PLWH
and their healthy controls. One-Way ANOVA and LSD
post-hoc comparison was used to compare variables be-
tween groups and by gender. Pearson’s product momentcorrelation analysis was used to test the relationships
between variables. Alpha level was set at p < 0.05.Results and discussion
Result
The participants’ ages ranged between 20 and 54 years.
The physical characteristics of the participants are
presented in Table 1. The PLWH and their healthy con-
trols were comparable in age, weight, height and body
mass index (p > 0.05).
The independent t-test comparison of the PCS and
MCS between the PLWH and control group are shown in
Table 2. The control group had a higher PCS than the
PLWH (51.92 ± 7.35 vs. 52.40 ± 7.61) but was not statisti-
cally significant (p > 0.05). The MCS of the PLWH was
found to be significantly higher than the MCS of the con-
trol group (p = 0.04). Table 3 shows the independent t-test
comparison of performance-based measures of functional
capacity between the PLWH and control group. From the
result, the control group had significantly higher 6MWD,
6MWW and VO2max respectively (p = 0.001).
One-Way ANOVA and LSD post-hoc comparison of
the performance-based functional exercise capacity mea-
sures, PCS and MCS by gender is presented in Table 4.
LSD post-hoc test was used to elucidate where the dif-
ferences observed in the F-ratio lies. From the result,
there were no significant gender differences in 6MWD,
6MWW and VO2max among PLWH (p > 0.05).
However, female participants with HIV/AIDS had sig-
nificantly higher PCS (48.97 ± 8.33 vs. 53.92 ± 5.99;
p < 0.05) while MCS was comparable (p > 0.05). On
the other hand, the male controls had significantly higher
values for 6MWD, 6MWW and VO2max (p < 0.05)
respectively, while PCS and MCS were comparable be-
tween both gender (p > 0.05). Pearson product moment
correlation between functional exercise capacity variables
(6MWD, 6MWW and VO2max) and each of PCS and
MCS is shown in Table 5. From the result, there
was no significant correlation between PCS and the
performance-based functional capacity measures for the
PLWH and control groups respectively (p > 0.05). Also,
there was no significant correlation between MCS and
Table 2 The independent t test comparison of the PCS
and MCS of PLWH and control group
PLWH Control group
Variable X±SD X±SD t-cal p-value
PCS 51.92 ± 7.35 52.40 ± 7.61 −0.277 0.782
MCS 73.00 ± 13.00 65.26 ± 9.27 2.952 0.040*
* Indicates significant difference between groups.
Abbreviations: PCS Physical-health Component Score, MCS Mental-health
Component Score.
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PLWH and control groups respectively (p > 0.05).
Discussion
This study assessed the HRQoL and PMFC of a
homogenous sample of clinical stage I PLWH and their
age-and-sex matched healthy controls. The PCS of the
SF-12 was employed in this study as a self-report meas-
ure of physical functional capacity. From the result,
there was no significant difference in the PCS between
PLWH and the controls. The finding on comparable
PCS between the PLWH and the controls may be a re-
flection of the clinical stage of the PLWH. Several stud-
ies using the SF-12 have shown that physical and mental
capacity decreases as the severity of HIV/AIDS increases
[46-49]. This present study recruited a homogenous
sample of PLWH in clinical stage 1 [asymptomatic stage]
who were currently on anti-retroviral therapy [HAART].
The symptoms and complications of HIV/AIDS includ-
ing muscle wasting, fatigue and disability as well as
prevalence of opportunistic infections have been shown
to be significantly reduced with the introduction of
highly active HAART [46,50]. It is adduced that the
asymptomatic stage and the effect of the HAART in
retarding the progression of HIV/AIDS disease may have
led to the comparable self-reported physical capacity be-
tween PLWH and the controls. Furthermore, the com-
parable PCS among the groups may be due to the young
age of the participants. In a cross sectional study,
Nojomi et al. [48] found PLWH below age 35 years to
have significantly better PCS than other age groups. The
mean age (35.68 ± 7.71 years) of PLWH that participatedTable 3 Independent t-test comparison of the measures
of functional exercise capacity between PLWH and
control group
PLWH Control group
Variable X±SD X±SD t - cal p-value
6MWD 442.95 ± 93.32 556.07 ± 93.41 −5.211 0.001*
6MWW 27853 ± 7501.63 37056 ± 7433.32 −5.301 0.001*
VO2max 30.07 ± 5.60 36.86 ± 5.60 −5.211 0.001*
* Indicates significant difference between groups.
Abbreviations: 6MWD 6 minute walk distance, 6MWW 6 minute walk work,
V02max Peak oxygen uptake.in this study is similar to that reported by Nojomi et al.
[48] as having better physical capacity than older PLWH.
The result of this study showed that the self-reported
MCS of PLWH was significantly higher than the healthy
controls. This finding contradicts the results of previous
studies that have found low mental health in PLWH
[51-54]. However, similar to the finding of this study,
Ostrow et al. [55] found that HIV/AIDS had a negative
effect on the physical health of PLWH, but not on their
mental health and attributed finding to the positive ef-
fect of HAART on the mental functioning of PLWH.
HAART has been reported to have a positive effect on
the life expectancy of PLWH, changing the view of HIV/
AIDS from a deadly disease to a potentially manageable
disease and consequently lead to improved survival and
reduction in opportunistic infections [47]. Apart from
the stage of no/minimal presence of symptoms of HIV/
AIDS, accessibility to HAART by PLWH at the clinic
where this study was conducted may have led to im-
provement in the PLWH perspective of the disease
resulting in a reported better mental health capacity. In
addition, the trend of people with terminal illnesses such
as HIV/AIDS towards a more spiritual disposition may
also explain the significantly higher mental health cap-
acity of PLWH found in this study. Nigeria is a religious
country where nearly everyone belongs to one religion
or the other. Anecdotal and empirical reports indicated
that Nigerian patients with chronic illnesses have high
level of religious inclinations [56,57]. High levels of reli-
gious inclinations have been reported among patients
with HIV/AIDS [58-62]. The possible religious dispos-
ition portends that PLWH may translate into being
positive-minded and over-psyched. PLWH often adopt
spirituality as a coping strategy to help reframe their
lives and also to bring a sense of meaning and purpose
to their lives in the face of an often devastating situation
[63-65]. Some other studies have found spirituality to be
positively associated with improvements in life satisfac-
tion, functional health status, health-related quality of
life, and overall well-being in PLWH [57,60,66,67]. An-
ecdotally, most of the patients seen in the course of this
study often speak in terms of their anticipation for better
health rather than accepting the present realities of the
HIV/AIDS infection. This form of communication may
account for the higher mental health component in
PLWH compared with the controls.
From this study, performance-based functional capacity
[6MWD, 6MWW and VO2 max] of PLWH was found to
be significantly lower than that of the controls. The result
on lower functional capacity among PLWH is consistent
with previous reports [68-70]. Specifically, from the result
of this study, 6MWD by the PLWH was significantly
shorter than that of the controls. This may be attributed
to muscle wasting and weakness, increased muscular
Table 4 One-Way ANOVA and LSD post-hoc comparison of performance-based functional exercise capacity measures,
PCS and MCS by gender
PLWH Control group
Male Female Male Female
n = 15 n = 22 n = 15 n = 22
Variable Mean ± S.D Mean ± S.D Mean± S.D Mean ± S.D F-ratio p-value
6MWD 466.22 ± 89.9a 427.09 ± 94.32a 600.09 ± 112.59b 526.07 ± 64.65c 12.356 0.001
6MWW 29001 ± 5648.5a 27070 ± 8679.91a 41594 ± 8149.44b 33962 ± 5070.20c 14.287 0.001
VO2max 2903.6 ± 564.85
a 2710.5 ± 857.99a 4162.9 ± 814.94b 3399.7 ± 507.01c 14.287 0.001
PCS 48.97 ± 8.33a 53.92 ± 5.99b 53.74 ± 5.77 51.49 ± 8.66 1.662 0.183
MCS 73.62 ± 9.74a 72.58 ± 15.03a 64.03 ± 7.50b 66.09 ± 10.39b 2.960 0.038
Abbreviations: 6MWD 6 minute walk distance, 6MWW 6 minute walk work, VO2max Peak oxygen uptake, PCS Physical-health Component Score, MCS Mental-health
Component Score, Superscripts (a,b,c,d).
For a particular variable, mode means with different superscript are significantly (P < 0.05) different. Mode means with same superscripts are not significantly
(P > 0.05) different. When only one contrast is significant, one of the cell means has no superscript attached. The pair of cell means that is significant has
different superscripts.
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that has been associated with HIV infection [7]. The work
done during the 6MWTas revealed by the 6MWW in this
study was also found to be significantly lower among the
PLWH. 6MWW is a product of the 6MWD [in meters]
and total body weight [in kilograms] [44]. Dourado [68]
suggested that several factors including demographic, an-
thropometric and physiological factors have an effect on
the result of the 6MWT. Obese participants usually have
reduced lean body mass, leading to a shorter 6MWD.
Carter et al. [71] suggested that the weight of the partici-
pant may have an effect on the amount of energy used up
during the work and thus the distance ambulated. It is be-
lieved that this may improve the accuracy and extend the
utility of the 6MWT [71]. Therefore, the 6MWW is a bet-
ter reflector of the work done during 6MWT than the
6MWD. Few studies among healthy subjects and patientsTable 5 Pearson product moment correlation between
functional exercise capacity variables and each of PCS
and MCS
PLWH Control group
Variable r (p-value) r (p-value)
PCS
6MWD 0.120 (0.479) 0.186 (0.271)
6MWW 0.007 (0.966) −0.087 (0.607)
VO2max 0.117 (0.485) 0.186 (0.271)
MCS
6MWD 0.006 (0.973) −0.176 (0.296)
6MWW 0.168 (0.321) 0.015 (0.932)
VO2max −0.016 (0.926) −0.176 (0.296)
Abbreviations: PCS Physical-health Component Score, MCS Mental-health
Component Score, 6MWD Six minute walk distance, 6MWW 6 minute walk
work, V02max Peak oxygen uptake.with chronic obstructive pulmonary disease [COPD] have
employed the use of the 6MWW [71,72]. However, there
seems to be no available study on 6MWW in PLWH.
VO2 max of PLWH in this study were found to be lower
than that of the healthy controls. This finding is similar to
a report by Rogea et al. [73] who found significantly lower
working capacity and the trend towards reduced VO2 max
in PLWH compared to healthy controls. Reduced VO2
max in PLWH may be as a result of reduced oxygen up-
take and reduced energy expenditure by PLWH. Pothoff
et al. [17] found reduced VO2 max in PLWH at the anaer-
obic threshold maximal exercise levels when compared
with healthy controls. Stringer et al. [18] suggested
physiological deconditioning as a causative factor of
reduced VO2 max in PLWH. However, physiological
deconditioning alone cannot account for the severity of
the limitation associated with PLWH [69]. Another ex-
planation for the reduced VO2 max observed in PLWH
especially those in clinical stage I may be due to reduced
ability of the exercising musculature to extract and
utilize oxygen and highly active anti-retroviral therapy
[HAART] also appears to limit peak oxygen uptake [19].
From this study, there were no significant gender dif-
ferences in the PMFC. However, females with HIV/AIDS
had significantly higher PCS while MCS was comparable
between both genders. In contrast, the male control sub-
jects had significantly higher values for 6MWD, 6MWW
and VO2max respectively, while PCS and MCS were com-
parable between both genders. To date, there is limited
data concerning women with HIV/AIDS as compared to
available data on their male counterparts. Furthermore,
there seems to be no available studies comparing func-
tional exercise capacity between male and female PLWH.
On the other hand, in concert with the findings of this
study, Holzemer et al. [74] demonstrated that HIV positive
women possessed higher self-reported quality of life than
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conducted in South Africa found that black females with
HIV had higher PCS compared with men with HIV.
From this study, there was no significant correlation
between self-report and performance-based measure of
functional capacity of PLWH and the healthy controls.
Literature on the correlation between self-report and
performance-based measure of functional capacity of
PLWH is scarce. However, a study by Vidrine et al. [76]
revealed no association between the functional status
and physical and mental health components assessed
with the SF-12 in PLWH.Clinical implications of the study
This study confirms the findings from many investigators
that PLWH are severely deconditioned and face functional
aerobic impairment compared to the general population.
However, to our knowledge, there seems to be a dearth of
studies that have actually compared PLWH with healthy
controls. This study found that those with HIV/AIDS had
significantly lower functional exercise capacity compared
to healthy persons of the same age and gender. In part,
the observed significantly lower VO2 max could have
resulted from impaired physical fitness revealed by signifi-
cant lower performance in 6MWT among PLWH. Laura
et al. [77] found 6MWT as a valid locomotor performance
test of functional capacity in PLWH. Some studies have
implicated the use of HAART among PLWH in decreased
locomotor performance as a result of direct adverse effects
on the muscle and peripheral neurotoxicity [50,78]. Fur-
thermore, this study found that psychosocial constructs
such as HRQoL does not influence functional exercise
capacity in clinical stage I PLWH. It is implied that
HRQoL and functional exercise capacity performance in
PLWH are not inter-dependent. Therefore, therapeutic in-
terventions targeted at improving functional exercise cap-
acity in PLWH may not adequately address psychosocial
impairment resulting from HIV/AIDS infection.Limitations of the study
The outcome of this study cannot be generalized to
PLWH in other clinical stages. This is because the clinical
stage of HIV/AIDS as well as the progression of the dis-
ease has a negative effect on the self-reported quality of
life of PLWH [48]. Furthermore, the healthy controls for
this study constituted of patients relatives and some health
workers at the centre of the study. Relative and caregivers
of PLWH have been linked with depression, psychological
burden and stress which may affect their overall mental
health as a result of poverty and financial struggles in-
duced by HIV/AIDS [79,80]. Therefore, a selection of
healthy controls from populations other than those who
have contacts with PLWH may yield a different mentalhealth assessment result. Nonetheless, future studies are
needed to put these reasonings into empirical analysis.
Conclusion
Self-report physical health capacity of PLWH and
healthy controls was comparable, while self-report men-
tal health capacity was higher in PLWH than the con-
trols. Performance-based functional capacity was lower
in clinical stage 1 PLWH compared to the healthy con-
trols. Overall, self-report and performance-based meas-
ure of functional exercise capacity of PLWH was not
inter-related. Therefore understanding the factors that
may influence exercise capacity of PLWH may help to
develop effective exercise programmes for PLWH.
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